Improved progression free survival (PFS), and rapid, sustained decrease in tumor perfusion among patients with advanced carcinoid treated with bevacizumab
Year: 2005
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: J. C. Yao, C. Ng, P. M. Hoff, A. T. Phan, K. Hess, H. Chen, X. Wang, J. L. Abbruzzese, J. A. Ajani
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2249288343
